HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Liguz-Lecznar Selected Research

4- aminobenzoyl- glycyl- prolyl- leucyl- alanine hydroxamic acid

6/2011Matrix metalloproteinase inhibition counteracts impairment of cortical experience-dependent plasticity after photothrombotic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Liguz-Lecznar Research Topics

Disease

2Shock
01/2022 - 12/2013
1Infarction (Infarctions)
06/2011
1Stroke (Strokes)
06/2011
1Ischemic Stroke
06/2011

Drug/Important Bio-Agent (IBA)

1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
01/2022
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
12/2013
1salicylhydroxamic acid (SHAM)IBA
06/2011
1Matrix Metalloproteinases (MMPs)IBA
06/2011
14- aminobenzoyl- glycyl- prolyl- leucyl- alanine hydroxamic acidIBA
06/2011
1Deoxyglucose (2 Deoxy D glucose)IBA
06/2011